| Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium ML Bondy, ME Scheurer, B Malmer, JS Barnholtz‐Sloan, FG Davis, ... Cancer 113 (S7), 1953-1968, 2008 | 1195 | 2008 |
| Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort D Il'yasova, LH Colbert, TB Harris, AB Newman, DC Bauer, S Satterfield, ... Cancer Epidemiology Biomarkers & Prevention 14 (10), 2413-2418, 2005 | 574 | 2005 |
| Metabolic slowing and reduced oxidative damage with sustained caloric restriction support the rate of living and oxidative damage theories of aging LM Redman, SR Smith, JH Burton, CK Martin, D Il'yasova, E Ravussin Cell metabolism 27 (4), 805-815. e4, 2018 | 501 | 2018 |
| Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors BS Melin, JS Barnholtz-Sloan, MR Wrensch, C Johansen, D Il'Yasova, ... Nature genetics 49 (5), 789-794, 2017 | 361 | 2017 |
| Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III GG Schwartz, D Il’yasova, A Ivanova Diabetes care 26 (2), 468-470, 2003 | 358 | 2003 |
| Urinary biomarkers of oxidative status D Il'yasova, P Scarbrough, I Spasojevic Clinica chimica acta 413 (19-20), 1446-1453, 2012 | 280 | 2012 |
| Cadmium and renal cancer D Il'yasova, GG Schwartz Toxicology and applied pharmacology 207 (2), 179-186, 2005 | 269 | 2005 |
| Germline mutations in shelterin complex genes are associated with familial glioma MN Bainbridge, GN Armstrong, MM Gramatges, AA Bertuch, ... Journal of the National Cancer Institute 107 (1), dju384, 2015 | 243 | 2015 |
| Branched-chain amino acids and insulin metabolism: the Insulin Resistance Atherosclerosis Study (IRAS) CC Lee, SM Watkins, C Lorenzo, LE Wagenknecht, D Il’yasova, YDI Chen, ... Diabetes care 39 (4), 582-588, 2016 | 174 | 2016 |
| Urinary isoprostane excretion is not confounded by the lipid content of the diet M Richelle, ME Turini, R Guidoux, I Tavazzi, S Metairon, LB Fay FEBS letters 459 (2), 259-262, 1999 | 162 | 1999 |
| Approaching a scientific consensus on the association between allergies and glioma risk: a report from the glioma international case-control study ES Amirian, R Zhou, MR Wrensch, SH Olson, ME Scheurer, D Il'Yasova, ... Cancer epidemiology, biomarkers & prevention 25 (2), 282-290, 2016 | 159 | 2016 |
| Update on triple‐negative breast cancer disparities for the United States: A population‐based study from the United States Cancer Statistics database, 2010 through 2014 LC Scott, LR Mobley, TM Kuo, D Il’yasova Cancer 125 (19), 3412-3417, 2019 | 157 | 2019 |
| Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography/mass spectrometry assay for urine 2, 3-dinor-5, 6-dihydro-15-F2t-isoprostane D Il'yasova, JD Morrow, A Ivanova, LE Wagenknecht Annals of epidemiology 14 (10), 793-797, 2004 | 117 | 2004 |
| Medical diagnostic radiation exposures and risk of gliomas F Davis, D Il'yasova, K Rankin, B McCarthy, DD Bigner Radiation research 175 (6), 790-796, 2011 | 115 | 2011 |
| GLIOGENE—an international consortium to understand familial glioma B Malmer, P Adatto, G Armstrong, J Barnholtz-Sloan, JL Bernstein, ... Cancer Epidemiology Biomarkers & Prevention 16 (9), 1730-1734, 2007 | 108 | 2007 |
| The epidemiology of tea consumption and colorectal cancer incidence L Arab, D Il'yasova The Journal of nutrition 133 (10), 3310S-3318S, 2003 | 97 | 2003 |
| Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem D Il’yasova, I Hertz-Picciotto, U Peters, JA Berlin, C Poole Cancer Causes & Control 16, 383-388, 2005 | 96 | 2005 |
| Effects of 2 years of caloric restriction on oxidative status assessed by urinary F2‐isoprostanes: The CALERIE 2 randomized clinical trial D Il'Yasova, L Fontana, M Bhapkar, CF Pieper, I Spasojevic, LM Redman, ... Aging Cell 17 (2), e12719, 2018 | 87 | 2018 |
| Urinary biomarkers of oxidative status in a clinical model of oxidative assault D Il'yasova, I Spasojevic, F Wang, AA Tolun, K Base, SP Young, ... Cancer epidemiology, biomarkers & prevention 19 (6), 1506-1510, 2010 | 86 | 2010 |
| Sex-specific glioma genome-wide association study identifies new risk locus at 3p21. 31 in females, and finds sex-differences in risk at 8q24. 21 QT Ostrom, B Kinnersley, MR Wrensch, JE Eckel-Passow, G Armstrong, ... Scientific reports 8 (1), 7352, 2018 | 80 | 2018 |
